Linkages between both systems were assessed with the overall aim of evaluating if the CD163-Nrf2/HO-1/NQO1 pathway is a novel target to treat inflammation and oxidative stress originating from intramural bleeding or the ILT in AAA. Here, CD163 is linked to triple-A syndrome.